Alzheimer disease: Advances in pathogenesis, diagnosis, and therapy

Clinical Chemistry

Volumn 57, Issue 5, 2011, Pages 664-669

  Pasic, Maria Diamandis ^a   Diamandis, Eleftherios P ^a,b   McLaurin, JoAnne ^a,c   Holtzman, David M ^d   Schmitt Ulms, Gerold ^a,c   Quirion, Rémi ^e,f,g  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g International Collaborative Research Strategy for Alzheimer's Disease   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN ANTIBODY; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA SECRETASE INHIBITOR; BIOLOGICAL MARKER; CASPASE; CHOLINESTERASE INHIBITOR; CLUSTERIN; CYTOPLASM PROTEIN; DIURETIC AGENT; GAMMA SECRETASE INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PRESENILIN 1; PRESENILIN 2; PROTEIN; VACCINE; VASODILATOR AGENT; VITAMIN B GROUP;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGGRESSION; AGING; ALZHEIMER DISEASE; AWARENESS; BLOOD PRESSURE REGULATION; BRAIN DISEASE; CELL DEATH; CELL ORGANELLE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; CONCENTRATION (PARAMETERS); CONFUSION; DEGENERATIVE DISEASE; DEMOGRAPHY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE COURSE; EXCITOTOXICITY; EXERCISE; FAMILIAL DISEASE; FATALITY; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HEALTH CARE SYSTEM; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; IRRITABILITY; LIFESPAN; LIFESTYLE MODIFICATION; LONG TERM CARE; MENTAL DETERIORATION; METABOLIC DISORDER; MICROGLIA; MISFOLDED PROTEIN; NEOCORTEX; NERVE CELL DEGENERATION; NEUROIMAGING; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; ONSET AGE; PARKINSON DISEASE; PATHOPHYSIOLOGY; POLYGLUTAMINE DISEASE; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIMARY PREVENTION; PROTEIN DEFECT; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; PUBLIC HEALTH PROBLEM; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE; TREATMENT INDICATION; TREATMENT PLANNING; VACCINATION; VASCULAR AMYLOIDOSIS; VASCULITIS; VITAMIN SUPPLEMENTATION;

AGE FACTORS; ALZHEIMER DISEASE; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; HUMANS;

EID: 79956082246     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.161828     Document Type: Note

References (0)